Adapting concepts from systems biology to develop systems exposure event networks for exposure science research

Biomarkers

Volumn 16, Issue 2, 2011, Pages 99-105

  Pleil, Joachim D ^a   Sheldon, Linda S ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

ADME; biological parameter; cytokine response; mixed effects model; Network diagram; protein adducts; variable clusters

Indexed keywords

CYTOKINE;

APOPTOSIS; BIOLOGY; CELL DEATH; DNA ADDUCT; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; HUMAN; LIPID PEROXIDATION; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVIEW; SCIENCE; SYSTEM EXPOSURE SCIENCE;

CAUSALITY; CLUSTER ANALYSIS; CONCEPT FORMATION; ENVIRONMENTAL EXPOSURE; HUMANS; MODELS, THEORETICAL; RISK ASSESSMENT; SYSTEMS BIOLOGY;

EID: 79951869058     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.541565     Document Type: Review

References (68)

1. Aggarwal K, Lee KH. 2003. Review: Functional genomics and proteomics as a foundation for systems biology, Brief Funct Genomic Proteomic. 2(3):175-184.
2. Ames BN. 1979. Identifying environmental chemicals causing mutations and cancer, Science 204(11):587-593.
3. Anderson MW, Eling TE. 1976. Studies on the uptake, metabolism, and release of endogenous and exogenous chemicals by use of the isolated perfused lung. Environ Health Perspect 16:77-81. (Pubitemid 8037532)
4. Angerer J, Ewers U, Wilhelm M. 2007. Human biomonitoring: state of the art. Int J Hyg Environ Health 210(3-4):201-28. (Pubitemid 46618114)
5. Arif JM, Gupta RC. 1996. Detection of DNA-reactive metabolites in serum and their tissue distribution in mice exposed to multiple doses of carcinogen mixtures: role in human biomonitoring. Carcinogenesis 17(10):2213-219. (Pubitemid 26372061)
6. Au WW. 2007. Usefulness of biomarkers in population studies: From exposure to susceptibility and to prediction of cancer. Int J Hyg Environ Health 210(3-4):239-246. (Pubitemid 46618099)
7. Baas J, Jager T, Kooijman B. 2009. Understanding toxicity as processes in time. Sci Total Environ. (epub doi:10.1016/j. scitotenv.2009.10.066)
8. Barabási http://www.nature.com.libproxy.lib.unc.edu/nrg/journal/ v5/n2/abs/nrg1272.html-a1 AL, Oltva ZN. 2004. Network biology: understanding the cell's functional organization. Nature Reviews Genetics 5:101-113.
9. Birnbaum LS. 2010. Applying research to public health questions: Biologically relevant exposures. Environ Health Perspect 118:4 A152.
10. Bonassi S, Neri M, Puntoni R. 2001. Validation of biomarkers as early predictors of disease. Mutat Res. 480-481:349-358. (Pubitemid 32744841)
11. Boothe VL, Shendell DG. 2008. Potential health effects associated with residential proximity to freeways and primary roads: review of scientific literature, 1999-2006. J Environ Health 70(8):33-41, 55-56. (Pubitemid 351525762)
12. Bruggeman FJ, Westerhoff HV. 2007. The nature of systems biology. Trends in Microbiology 15(1):45-50. (Pubitemid 46043550)
13. Coghlin J, Gann PH, Hammond SK, Skipper PL, Taghizadeh K, Paul M, Tannenbaum SR. 1991. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero. J Natl Cancer Inst. 83(4):274-80.
14. Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420, 860-867. (Pubitemid 36019639)
15. Crump KS, Chen C, Chiu WA, Louis TA, Portier CJ, Subramaniam RP, White PD. 2010. What role for biologically based dose-response models in estimating low-dose risk? Environ Health Perspect 118(5):585-588.
16. Domany E. 2003. Cluster analysis of gene expression data. Journal of Statistical Physics 110(3-6): 1117-1139.
17. Dorne JL. 2009. Metabolism, variability and risk assessment. Toxicology 268(3):156-64.
18. Duramad P, Tager IB, Holland NT. 2007. Cytokines and other immunological biomarkers in children's environmental health studies. Toxicol Lett 172(1-2):48-59. (Pubitemid 47126222)
19. Edwards SW, Preston RJ. 2008. Forum: Systems biology and mode of action based risk assessment. Tox Sci 106(2):312-318.
20. Ekins S, Nikolsky Y, Nikolskaya T. 2005. Review: Techniques: Application of systems biology to absorption, distribution, metabolism, and toxicity. Trends in Pharmacological Sciences 26(4): 202-209. (Pubitemid 40432655)
21. Farmer PB. 1995. Monitoring of human exposure to carcinogens through DNA and protein adduct formation. Toxicol Lett 82/83:757-762. (Pubitemid 26057532)
22. Feldmann M, Maini RN, 2001. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?. Annu Rev Immunol. 19: 163-96. (Pubitemid 32368033)
23. Funk WE, Li H, Iavarone AT, Williams ER, Riby J, Rappaport SM. 2010. Enrichment of cysteinyl adducts of human serum albumin. Anal Biochem. 400(1):61-8.
24. Gallagher JE, Cohen-Hubal EA, Edwards SW. 2009. Biomarkers for Environmental Exposure. In: Biomarkers of toxicity: A New Era in Medicine. (Vishal S. Vaidya VS and Bonventre JV eds) Hoboken NJ:John Wiley and Sons, Inc. Chapter 22.
25. Gracy, RW, Talent JM, Kong Y, Conrad CC. 1999. Reactive oxygen species: the unavoidable environmental insult? Mutation Research 428:17-22. (Pubitemid 29389672)
26. Harrell FE. 2002. Regression Modeling Strategies, Chapt. 4. In: Multivariable modeling strategies. New York:Springer-Verlag.
27. Hippe A, Homey B, Mueller-Homey A. 2010. Chemokines. Recent Results Cancer Res. 180:35-50.
28. Hubal EA. 2009. Biologically relevant exposure science for 21st century toxicity testing. Toxicol Sci. 111(2):226-32.
29. Jansen RS, Rosing H, Schellens JHM, Beijnen JH. 2009. Protein versus DNA as a marker for peripheral blood mononuclear cell counting. Analytical and Bioanalytical Chemistry, 395(3): 863-867.
30. Jenkins GJ, Zaïr Z, Johnson GE, Doak SH. 2009. Genotoxic thresholds, DNA repair, and susceptibility in human populations. Toxicology (epub doi:10.1016/j.tox.2009.11.016).
31. Karalliedde LD, Edwards P, Marrs TC. 2003. Variables influencing the toxic response to organophosphates in humans. Food Chem Toxicol. 41(1):1-13. (Pubitemid 35346767)
32. Kettenring JR. 2006. The practice of cluster analysis. Journal of Classification 23: 3-30. (Pubitemid 44099757)
33. Kim V, Rogers TJ, Criner GJ. 2008. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 5(4):478-85. (Pubitemid 351669174)
34. Krishnan SM, Dixit NM. 2009. Estimation of red blood cell lifespan from alveolar carbon monoxide measurements. Transl Res 154(1):15-17.
35. Loscalzo J, Kohane I, Barabasi AL. 2007. Human disease classification in the postgenomic era: A complex systems approach to human pathobiology. Mol Syst Biol 3:124.
36. Meyer MJ, Bechtold WE. 1996. Protein Adduct Biomarkers: State of the Art. Environ Health Perspect 104(Supp. 5):879-882. (Pubitemid 26402325)
37. Montón C, Torres A. 1998. Lung inflammatory response in pneumonia. Monaldi Arch Chest Dis. 53(1):56-63. (Pubitemid 28239299)
38. Needham LL. 2008. Introduction to biomonitoring. Journal of Chemical Health & Safety 15(6):5-7.
39. Neri M, Ugolini D, Bonassi S, Fucic A, Holland N, Knudsen LE, Srám RJ, Ceppi M, Bocchini V, Merlo DF. 2006. Children's exposure to environmental pollutants and biomarkers of genetic damage. II. Results of a comprehensive literature search and meta-analysis. Mutat Res. 612(1):14-39. (Pubitemid 43038815)
40. Nishimura M, Kuboi Y, Muramoto K, Kawano T, Imai T. 2009. Chemokines as novel therapeutic targets for inflammatory bowel disease. Ann N Y Acad Sci 1173:350-6.
41. Noort D, van Zuylen A, Fidder A, van Ommen B, Hulst AG. 2008. Protein adduct formation by glucuronide metabolites of permethrin. Chem Res Toxicol. 21(7):1396-406.
42. Perera FP. 1997. Environment and Cancer: Who Are Susceptible? Science 278(5340):1068-1073. (Pubitemid 27517877)
43. Pleil JD. 2009. Influence of systems biology response and environmental exposure level on between-subject variability in breath and blood biomarkers. Biomarkers 14(8):560-571.
44. Pleil JD. 2008. The Role of Exhaled Breath Biomarkers in Environmental Health Science. Journal of Toxicology and Environmental Health: Part B: Critical Reviews, 11:613-626.
45. Pleil JD, Kim D, Prah J, Rappaport SM, 2007. Exposure reconstruction for reducing uncertainty in risk assessment: Example using MTBE biomarkers and a simple pharmacokinetic model, Biomarkers 12(4):331-348. (Pubitemid 46952297)
46. Pleil JD and Lorber MN. 2007. Relative Congener Scaling of Polychlorinated Dibenzo-p-dioxins and Dibenzofurans to Estimate Building Fire Contributions in Air, Surface Wipes, and Dust Samples. Environ Sci and Tech 41(21):7286-7293. (Pubitemid 350071636)
47. Rappaport.,SM, Kupper LL. 2008. Quantitative Exposure Assessment. El Cerrito, CA: Rappaport.
48. Rappaport SM, Waidyanatha S, Qu Q, Shore R, Jin X, Cohen B, Chen LC, Melikian AA, Li G, Yin S, Yan H, Xu B, Mu R, Li Y, Zhang X, Li K. 2002. Albumin adducts of benzene oxide and 1,4-benzoquinone as measures of human benzene metabolism. Cancer Res. 62(5):1330-1337. (Pubitemid 34407788)
49. Ritz B, Wilhelm M. 2008. Ambient air pollution and adverse birth outcomes: methodologic issues in an emerging field. Basic Clin Pharmacol Toxicol 102(2):182-90. (Pubitemid 351143419)
50. Robroeks CM, Rijkers GT, Jöbsis Q, Hendriks HJ, Damoiseaux JG, Zimmermann LJ, van Schayck OP, Dompeling E. 2010. Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children. Clin Exp Allergy 40(1):77-84.
51. Rubino FM, Pitton M, Di Fabio D, Colombi A. 2009. Toward an "omic" physiopathology of reactive chemicals: thirty years of mass spectrometric study of the protein adducts with endogenous and xenobiotic compounds. Mass Spectrom Rev. 28(5):725-84.
52. Rusyn I, Datson GP. 2010. Computational Toxicology: Realizing the promise of the toxicity testing in the 21st century. Environ Health Perspect doi:10.1289/ehp.1001925 [online 18 May 2010].
53. Sheldon LS, Cohen-Hubal EA. 2009. Commentary: Exposure as part of a systems approach for assessing risk", Environ Health Perspect 117(8):1181-1184.
54. Simmons PT, Portier CJ. 2002. Toxicogenomics: the new frontier in risk analysis. Carcinogenesis 23(6):903-905. (Pubitemid 34752945)
55. Singer JD, 1998. Using SAS PROC MIXED to fit multi-level models, hierarchical models, and individual growth models. Journal of Educational and Behavioral Statistics 24(4):323-355. (Pubitemid 128474255)
56. Sirera R, Salvador A, Roldan I, Talens R, Gonzales-Molina A, Rivera M. 2003. Quantification of proinflammatory cytokines in the urine of congestive heart failure patients. Its relationship with plasma levels. The European Journal of Heart Failure 5:27-31. (Pubitemid 36205541)
57. Smith MT, Rappaport SM. 2009. Editorial: Building exposure biology centers to put the E into GxE interaction studies. Environ Health Perspect 117(8): A334-335.
58. Sobus JR, Pleil JD, McClean MD, Herrick RF, Rappaport SM. 2010. Biomarker Variance Component Estimation for Exposure Surrogate Selection and Toxicokinetic Inference. Toxicology Letters. 199(3):247-253.
59. Stark J. 2008. Overview: Systems biology: a noisy coming of age. Current Opinion in Biotechnology 19:351-353.
60. Stenfors N, Nordenhäll C, Salvi SS, Mudway I, Söderberg M, Blomberg A, Helleday R, Levin JO, Holgate ST, Kelly FJ, Frew AJ, Sandström T. 2004. Different airway inflammatory responses in asthmatic and healthy humans exposed to diesel. Eur Respir J. 23(1): 82-6. (Pubitemid 38088501)
61. Stenvinkel P, Alvestrand A. 2002. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial. 15(5):329-37.
62. Swenberg JA, Koc H, Upton PB, Georguieva N, Ranasinghe A, Walker VE, Henderson R. 2001. Using DNA and hemoglobin adducts to improve the risk assessment of butadiene. Chem Biol Interact. 135-136:387-403. (Pubitemid 32530499)
63. Tao F, Gonzalez-Flecha B, Kobzik L. 2003. Reactive oxygen species in pulmonary inflammation by ambient particulates. Free Radic Biol Med. 35(4):327-40. (Pubitemid 37289164)
64. Törnqvist M, Fred C, Haglund J, Helleberg H, Paulsson B, Rydberg P. (2002). Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications. J Chromatogr B Analyt Technol Biomed Life Sci 778(1-2): 279-308.
65. Tsiligianni I, Antoniou KM, Kyriakou D, Tzanakis N, Chrysofakis G, Siafakas NM, Bouros D. 2005. Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis. BMC Pulm Med. 5:8.
66. Van der Vliet A, Hristova M, McCarthy S, Kasahara D. 2008. Cellular and environmental electrophiles: Balancing redox signaling, inflammation, and cell death pathways. Chapter 3: Oxidants in biology: A question of balance. (Valacchi G and Davis PA eds). Dordrecht Netherlands:Springer.
67. Wessels D, Barr DB, Mendola P. 2003. Use of biomarkers to indicate exposure to children to organophosphate pesticides: Implications for a longitudinal study of children's environmental health. Environ Health Perspect 111(16):1939-1946. (Pubitemid 37541207)
68. Wild CP. 2005. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 14(8):1847-50. (Pubitemid 41161186)